Clinical Trials Browser

Phase 1 × Interventional × Solid Tumors, KRAS Mutation × Clear all

NCT04973163 2026-02-17

A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumors, KRAS Mutation

NCT04742556 2024-09-19

A Study to Test Different Doses of BI 3011441 in Japanese People With Different Types of Advanced Cancer (NRAS/KRAS Mutation Positive)

Phase 1 Completed

15 enrolled 18 charts

Other solid neoplasm

Solid Tumors, KRAS Mutation

NCT04835714 2023-02-01

A Study to Find a Safe and Effective Dose of BI 1701963 Alone and in Combination With BI 3011441 in Patients With Advanced Cancer and a Certain Mutation (Kirsten Rat Sarcoma Viral Oncogene Homologue [KRAS])

Phase 1 Terminated

Other solid neoplasm

Solid Tumors, KRAS Mutation